Switch Therapeutics

South San Francisco, United States · Founded 2020 · $52.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$52.0M
Last Round
$52.0M Series AMar 2023
Rounds
2

About

Switch Therapeutics is a preclinical-stage biotechnology company founded in 2020 to develop therapeutic applications from RNA interference (RNAi) research pioneered at Caltech, Harvard Medical School, and City of Hope. The company's proprietary CASi (Conditional Activation Switch) platform integrates nucleic acid nanotechnology and RNA biology to create biomarker-gated genetic medicines — therapeutics that activate only in diseased cells expressing specific molecular signals. This programmable, cell-selective approach targets diseases of the central nervous system (CNS) and beyond. Switch raised $52M and moved into its own facility in South San Francisco in early 2022 upon publicly announcing its launch.

Summary

Switch Therapeutics is a Life Sciences company based in South San Francisco, United States, founded in 2020. It has raised $52.0M in total across 2 rounds, most recently a $52.0M Series A round in Mar 2023. Investors include Insight Partners, UCB and Eli Lilly.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2023
$52.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Switch Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/switch-therapeutics"><img src="https://indexed.vc/api/badge/company/switch-therapeutics" alt="Switch Therapeutics on Indexed.vc" width="260" height="76" /></a>